2 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow MP0250: new trials by email Literature Review of MP0250 trials Research Report on MP0250
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Multiple Myeloma MP0250 plus BOR+DEX - Multiple Myeloma in Relapse | Phase 1 / Phase 2 | Completed | Molecular Partners AG | 33 | 2017-05-23 | 2021-08-25 |
| First-in-human Study to Investigate the Safety, Tolerability and Blood Levels of the Test Drug MP0250 in Cancer Patients MP0250 - Neoplasms | Phase 1 / Phase 2 | Completed | Molecular Partners AG | 58 | 2014-07-01 | 2019-08-07 |
Neoplasms (1)
Austria (1) · Czechia (1) · Denmark (1) · Germany (1) · Italy (1) · Poland (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
2014 (1), 2016 (1)